The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …
within a collaboration between the World Health Organization (WHO), the Society for …
Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients
WM Gerding, M Tembrink… - … Journal of Cancer, 2022 - Wiley Online Library
Cytogenetic diagnostics play a crucial role in risk stratification and classification of myeloid
malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) …
malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) …
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
O Pozdnyakova, A Orazi, K Kelemen… - American journal of …, 2021 - academic.oup.com
Objectives To summarize cases submitted to the 2019 Society for Hematopathology/
European Association for Haematopathology Workshop under the category of …
European Association for Haematopathology Workshop under the category of …
The international consensus classification of eosinophilic disorders and systemic mastocytosis
SA Wang, A Orazi, J Gotlib, A Reiter… - American journal of …, 2023 - Wiley Online Library
Based on new data and increased understanding of disease molecular genetics, the
international consensus classification (ICC) has made several changes in the diagnosis and …
international consensus classification (ICC) has made several changes in the diagnosis and …
Updates on eosinophilic disorders
This review addresses changes and updates in eosinophilic disorders under the
International Consensus Classification (ICC). The previous category of myeloid/lymphoid …
International Consensus Classification (ICC). The previous category of myeloid/lymphoid …
[HTML][HTML] Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract
CR Soderquist, N Patel, VV Murty, S Betman… - …, 2020 - ncbi.nlm.nih.gov
Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract are rare clonal T-cell
diseases that more commonly occur in the intestines and have a protracted clinical course …
diseases that more commonly occur in the intestines and have a protracted clinical course …
JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, arising from
immature lymphocytes that show uncontrolled proliferation and arrested differentiation …
immature lymphocytes that show uncontrolled proliferation and arrested differentiation …
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes
J Schwaab, N Naumann, J Luebke… - American journal of …, 2020 - Wiley Online Library
We report on 18 patients with myeloid neoplasms and associated tyrosine kinase (TK) fusion
genes on treatment with the TK inhibitors (TKI) ruxolitinib (PCM1‐JAK2, n= 8; BCR‐JAK2, n …
genes on treatment with the TK inhibitors (TKI) ruxolitinib (PCM1‐JAK2, n= 8; BCR‐JAK2, n …